Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lagu
Bharat Lagu, Hillsborough, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080300264 | SUBSTITUTED THIATRIAZAACENAPHTHYLENE-6-CARBONITRILE KINASE INHIBITORS - The present invention is directed to substituted thiatriazaacenaphthylene-6-carbonitrile compounds of formula (I): | 12-04-2008 |
| 20090099143 | TETRAHYDRO-INDAZOLE CANNABINOID MODULATORS - This invention is directed to a tetrahydro-indazole cannabinoid modulator compound of formula I: | 04-16-2009 |
| 20100105728 | DIHYDRO-[1H]-QUINOLIN-2-ONE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES - The present invention relates to compounds of Formula (I), | 04-29-2010 |
Bharat Lagu, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100041663 | Organic Compounds as Smo Inhibitors - The present invention relates generally to novel compounds relating to the diagnosis and treatment of pathologies relating to the Hedgehog pathway, including but not limited to tumor formation, cancer, neoplasia, and non-malignant hyperproliferative disorders. The present invention includes novel compounds, novel compositions, methods of their use and methods of their manufacture, where such compounds are generally pharmacologically useful as agents in therapies whose mechanism of action involve methods of inhibiting tumorigenesis, tumor growth and tumor survival using agents that inhibit the Hedgehog and Smo signaling pathway. | 02-18-2010 |
Kiran Shankar Lagu, Vaudreuil-Dorion CA
| Patent application number | Description | Published |
|---|---|---|
| 20100204292 | Pharmaceutical compositions comprising intra-and extra-granular fractions - A pharmaceutical composition comprising i) an intra-granular fraction containing a pharmaceutically acceptable active component and a first excipient and ii) an extra-granular fraction containing a second excipient. The pharmaceutical composition is characterized by being substantially surfactant-free and by exhibiting a rapid-dissolution profile. | 08-12-2010 |